Founded in 2018 by an experienced group of cannabis industry pioneers, Materia is a highly ambitious pharmaceutical company that strives to be a global leader in the burgeoning cannabis industry.
With a focus on downstream value-add activities like manufacturing, extraction, supply and distribution, Materia aims to be the supplier of choice in both the medical cannabis and wellbeing space.
Materia’s management team draws on deep cannabis, pharmaceutical and CPG experience with extensive expertise in navigating complex regulatory environments, specifically in Europe.
Materia is on a mission to be the most trusted name in enabling access to cannabis, worldwide.
We collaborate with cannabis suppliers, government officials, healthcare providers and retailers to realise the full health and economic benefits of cannabis.
The expertise we offer in navigating complex regulatory ecosystems – combined with our unparalleled industry network – ensures that our partners enter global markets with confidence.
Our leading market and product knowledge enables us to supply the formulations and product portfolios that best address the needs of our patients and consumers.
Government officials and healthcare providers around the world seek Materia because we deliver quality medical grade products and subject matter expertise at the highest levels of integrity.
Our passionate team of industry-leading professionals works in symphony with our partners. We align our own success metrics to theirs. And by committing to the relentless pursuit of knowledge and exceptional service, our relationships go far beyond transactions, maximizing value for every Materia stakeholder.
Scientific progress is key to the future success of the global cannabis industry. That’s why at the heart of Materia’s business is our ethos of innovation.
By undertaking cutting-edge research through partnerships with world class scientists, we aim to develop clinically tested pharmaceutical cannabis products for a range of indications.
Public interest in the health benefits of CBD continues to grow globally as the compound establishes itself as a household name.
Materia views the CBD marketas being highly fragmented and suffering from a great deal of consumer confusion around specific health benefits, appropriate dosing and even interpreting label information.
To help the market reach its potential, Materia helps established, reputable brands enter core European markets, such as the UK, by offering a turnkey solution as a local partner. In leveraging our manufacturing and distribution network, Materia represents a portfolio of leading brands who will define the future of the CBD category.
Expertise Throughout the Value Chain
Our European Focus
Materia's North American Headquarters
355 Adelaide Street West, Floor 6, Toronto, ON M5V 1S2
Materia Deutschland GmbH
℅ Spaces, Gorch-Fock-Wall 1a, 20354 Hamburg
Materia's UK Headquarters
15 Theed Street, London, SE1 8ST
Materia's Malta Headquarters
Bldg 102, Hal Far Industrial Estate, HHF308, Hal Far BBG3000